Pelago Bioscience is a company that delivers target engagement studies to accelerate preclinical and clinical drug discovery and diagnostics development. It offers Cellular Thermal Shift Assay (CETSA) technology that provides a quantitative measure of target engagement and physiologically relevant readout of affinity.